Provider review
OrderlyMeds review
Answers the dose question as a plain yes or no — and the answer is no, the price never moves.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$149/mo semaglutide, $299 tirzepatide
Visit OrderlyMedsDoes the price increase with the dose? No — which cuts both ways. Hold a quarter dose and you pay the full-dose rate. The cheap figures on the page are two-month starter blocks for new customers, and the standing rates are double them.
Price as published
OrderlyMeds
$149/mo semaglutide, $299 tirzepatide
FDA warning letter · OrderlyMeds · June 2026 · addressed to OrderlyMeds LLC dba OrderlyMeds. Details in our review.
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
A quarter dose costs exactly what a full dose costs here, and OrderlyMeds says so in a plain FAQ — does the price increase with the dose, no, all of our medication is available for the same price per dosage. If you are taking less to spend less, that is the structure charging you for medicine you never use. Give it real credit for the disclosure most providers skip: it publishes what happens when the promotion ends, by name and by number, in its own words, and labels every discounted tier as new-customers-only at the point of sale rather than in the terms. Two things will still cost you. The half-price figures are two-month starter blocks, and the standing rates that follow are double them. And that block ships both months in one shipment, so a patient who stops at week three has already paid for and received week eight's vial.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are starting low and expect to climb, and want the price to hold when you do.
- You want the post-promotion rate stated in writing before you start.
- You want to see the brand-name prices you are being compared against on the same page.
- You want 50-state clinician coverage stated plainly.
Look elsewhere if
- You are taking less to spend less. This charges you the full rate for a fraction of the drug.
- You are budgeting from the discounted figure. It is a two-month starter block for new customers, and the standing rate is double.
- You want the option to stop mid-block. Both months ship at once.
- You want to check the flat claim against a dose range. No milligram figure is published.
What it actually costs
Price as published
$149/mo semaglutide, $299 tirzepatide
- Vs median
- $26/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Same price at every dose
One stated price across doses. A lower dose does not automatically reduce the bill. Compare the complete medication, membership, laboratory and shipping quotes before assuming another plan costs less.
113 of the 548 programs here price a small dose this way. Answers the flat-price question with a direct yes in its own FAQ, covering all its medication. The half-price figures are new-customer two-month blocks, and the standing rates that follow are double — which the company itself publishes, by name and by number. The starter block ships both months at once, so a patient who stops early has already paid for and received the second vial.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Flat at every dose
What it does well
- Answers the dose-price question as a direct yes/no FAQ — "Does the price increase with the dose? No! All of our medication is available for the same price per dosage" — rather than a marketing adjective
- Publishes the post-promotion price explicitly, by name and by number: "What price will I pay for my medications after I finish the SimpleStart program? Your next month of medication will be priced at our standard monthly rates", followed by the actual figures
- Labels every discounted tier with the restriction that applies to it — "only available to new customers" — at the point of sale rather than in the terms
- Prices the brand-name alternatives it competes with on the same page: Wegovy $1,839, Zepbound $1,498
- States 50-state clinician coverage plainly
- Carries a correctly worded compounding disclaimer, including that "FDA registration of the facility does not constitute FDA approval or endorsement of any compounded medication"
Pharmacy, labs and oversight
OrderlyMeds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What OrderlyMeds publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to OrderlyMeds in June 2026. It is addressed to OrderlyMeds LLC dba OrderlyMeds — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how OrderlyMeds is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
OrderlyMeds sells compounded semaglutide and compounded tirzepatide as weekly injections, with a standing monthly rate and two new-customer starter tiers sold as two-month prepaid blocks. Its FAQ answers the dose-price question directly and states the post-promotion rate by number. It says it connects patients to licensed healthcare professionals in all 50 states, and carries a correctly worded compounding disclaimer noting that FDA registration of a facility is not FDA approval of a compounded medication. No compounding pharmacy or outsourcing facility is named.
The honest cons
ONE PRICE AT EVERY DOSE IS THE STRUCTURE THIS SITE EXISTS TO FLAG. "Does the price increase with the dose? No!" means a patient deliberately holding a quarter dose pays the identical $149 as one at the top of the range
- THE HALF-PRICE FIGURES ARE NEW-CUSTOMER, TWO-MONTH BLOCKS. $74 and $149 per month apply to a 2-month starter only; the standing rates are double — $149 and $299
- THE STARTER BLOCK SHIPS TWO MONTHS AT ONCE, so a patient who stops at week three has already paid for and received week eight's vial
- No milligram figure is published against any price, so the flat claim is credible but unspecified as to range
- "Get $3,700 of support for FREE when you buy with us" values the non-medication services with no breakdown of how the figure is arrived at
- No compounding pharmacy or outsourcing facility is named — only "state-licensed pharmacies or FDA-registered outsourcing facilities, as applicable"
- No week count is published against "per month", so an annual cost cannot be computed exactly
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
OrderlyMeds is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way OrderlyMeds does. Both are partners: we may earn a commission if you start care through these links.
Partner
bmiMD
$159/mo microdose — same as its full dose
Same price at every dose
Partner
WellMedr
$59–$99/mo, but only on a 12-month plan
Same price at every dose
Where this sits
#97 of 548
Ordered with the companies that pay us first, and OrderlyMeds is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MEDGm
$299/mo sema · $399/mo tirz after intake
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Same price at every dose
- Dispensed
- Compounded by RedRock · Health Warehouse · Precision Medicine · Triad Rx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MEDGm review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.